Adrenal atrophy overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(6 intermediate revisions by 2 users not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{MHP}}
{{CMG}}; {{AE}} {{MHP}}


Adrenal glands, also known as suprarenal glands, are small, triangular-shaped glands located on top of both kidneys. They produce hormones that help regulate your metabolism, immune system, blood pressure, response to stress and other essential functions. Adrenal atrophy may be caused by loss of ACTH and trophic support of the adrenal cortex (due to exogenous corticosteroid overuse) or direct damage to the tissue caused by infections ([[TB]], [[CMV]], [[histoplasmosis]], [[paracoccidioidomycosis]]), vascular impairments (hemorrhage from [[sepsis]], [[adrenal vein thrombosis]], [[HIT]]), deposition disease ([[hemochromatosis]], [[amyloidosis]], [[sarcoidosis]]), or drugs (azole anti-fungals, etomidate, rifampin, anticonvulsants) or cytotoxic agents such as mitotane. The onset of clinical manifestations is dependent to the etiology of the atrophy. However, the symptoms of the adrenal atrophy usually develop in patient’s 30s to 50s and in their 60s in the case of secondary adrenal atrophy. Common complications of the adrenal atrophy and its malfunction include hypoglycemia, dehydration, weight loss, and disorientation. Prognosis is generally poor, due to the irreversibility of atrophy and the one out of 200 patients with adrenal atrophy die each year due to the adrenal crisis. As the disease consists of the irreversible atrophy of the adrenal gland treatment of the adrenal atrophy is a conservative treatment, including hormone replacement therapy and managing the adrenal crisis state.
==Overview==
[[Adrenal atrophy]] is the shrinkage of [[adrenal gland]] due to reduce in size and number of adrenal gland [[cells]].
 
==Historical Perspective==
We have had many famous cases of adrenal atrophy like president John F. Kennedy, king Henry VIII.
 
==Classification==
There is no established system for the classification of adrenal atrophy. However, some authors have classified it by causes.
 
==Pathophysiology==
The adrenal glands produce hormones that help regulate your metabolism, immune system, blood pressure, response to stress and other essential functions. Adrenal atrophy may be caused by a loss of ACTH and trophic support of the adrenal cortex or direct damage to the tissue due to exogenous [[corticosteroid]] overuse or an endocrine disease, affecting the glands.
 
==Causes==
Adrenal atrophy may be caused by a loss of [[ACTH]] and trophic support of the [[adrenal]] [[cortex]] or direct damage to the tissue.
 
==Adrenal atrophy differential diagnosis==
There are some conditions that cause salt wasting, [[nausea]], [[vomiting]], [[hyponatremia]], [[hyperkalemia]] and finally adrenal hormone imbalance which should be differentiated from adrenal atrophy.
 
==Epidemiology and Demographics==
Generally, secondary adrenal atrophy is more common than primary adrenal atrophy and is more common in women. Clinical manifestations occur in 30s to 50s in primary and in 60s in secondary adrenal atrophy.
 
==Risk Factor==
There are no established risk factors for adrenal atrophy.
 
==Screening==
There is insufficient evidence to recommend routine screening for adrenal atrophy. However, the adrenal-hypopituitary axis can be evaluated with [[sodium]], [[potassium]], [[renin]], [[aldosterone]], [[cortisol]], [[DHEA]], [[ACTH]], and [[CRH]] levels.
 
==Natural history, complications and prognosis==
Adrenal atrophy is mainly due to the prolonged malfunction of the adrenal gland. If left untreated, the patients are mainly at risk of a lethal condition, called adrenal crisis. Common complications of the adrenal atrophy and its malfunction include [[hypoglycemia]], [[dehydration]], weight loss, and disorientation. Prognosis is generally poor, due to the irreversibility of atrophy.
 
==Diagnosis==
===History and Symptoms===
The most common signs and symptoms of adrenal atrophy are [[fatigue]], weight loss, [[salt craving]], [[abdominal pain]] and [[myalgia]].
 
===Physical Examination===
In the physical examination the patients may have [[hypotension]], [[hyperpigmentation]], [[depigmentation]] in [[autoimmune cases]].
 
===Laboratory Findings===
The labs include random [[cortisol]], serum [[ACTH]], [[aldosterone]] and [[renin]], [[potassium]] and [[sodium]], [[ACTH stimulation test]] and CRH stimulation test.
 
===Electrocardiogram===
There are no specific [[ECG]] changes due to adrenal atrophy. However it consequences such as [[hyperkalemia]] may change ECG.
 
===X-ray===
There are no [[x-ray]] findings associated with adrenal atrophy.
 
===Ultrasound===
The adrenal glands can be studied in [[ultrasound]] imaging and each [[abdominal]] ultrasound. Any new incidental [[mass]], larger than 1cm should be evaluated with [[CT-scan]] or [[MRI]].
 
===CT scan===
A [[CT]] of the adrenal glands can be used to check for structural abnormalities of the adrenal glands.
 
===MRI===
An [[MRI]] of the [[pituitary]] can be used to check for structural abnormalities of the pituitary.
 
===Other Imaging Findings===
There are no other [[imaging]] findings associated with adrenal atrophy.
 
===Other Diagnostic Studies===
There are no other [[Diagnosis|diagnostic studies]] associated with adrenal atrophy.
 
==Treatment==
===Medical Therapy===
Treatment of adrenal atrophy is conservative. In case of adrenal crisis [[IV fluid]] and [[steroid]] are recommended. For long-term management supplementing with [[steroid]] and [[mineralocorticoid]] is necessary.
 
===Surgery===
[[Surgery]] can be done in case of micro or macro [[adenomas]] of brain or other [[glandular]] [[tumors]] that may lead to adrenal atrophy.
===Primary Prevention===
Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous [[corticosteroid]] drugs.
 
===Secondary Prevention===
The secondary prevention of the adrenal atrophy is also known as early diagnosis of any [[steroid]] or [[mineralocorticoid]] deficiency in the body and its early appropriate treatments.
 
===Cost-Effectiveness of Therapy===
There is no cost-effectiveness of therapy for adrenal atrophy.
 
===Future or Investigational Therapies===
There are no future or investigational therapies for adrenal atrophy.
 
==References==
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 08:21, 29 August 2023

Adrenal atrophy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adrenal atrophy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adrenal atrophy overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adrenal atrophy overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adrenal atrophy overview

CDC on Adrenal atrophy overview

Adrenal atrophy overview in the news

Blogs on Adrenal atrophy overview

Directions to Hospitals Treating Adrenal atrophy

Risk calculators and risk factors for Adrenal atrophy overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Hadipour, M.D.[2]

Overview

Adrenal atrophy is the shrinkage of adrenal gland due to reduce in size and number of adrenal gland cells.

Historical Perspective

We have had many famous cases of adrenal atrophy like president John F. Kennedy, king Henry VIII.

Classification

There is no established system for the classification of adrenal atrophy. However, some authors have classified it by causes.

Pathophysiology

The adrenal glands produce hormones that help regulate your metabolism, immune system, blood pressure, response to stress and other essential functions. Adrenal atrophy may be caused by a loss of ACTH and trophic support of the adrenal cortex or direct damage to the tissue due to exogenous corticosteroid overuse or an endocrine disease, affecting the glands.

Causes

Adrenal atrophy may be caused by a loss of ACTH and trophic support of the adrenal cortex or direct damage to the tissue.

Adrenal atrophy differential diagnosis

There are some conditions that cause salt wasting, nausea, vomiting, hyponatremia, hyperkalemia and finally adrenal hormone imbalance which should be differentiated from adrenal atrophy.

Epidemiology and Demographics

Generally, secondary adrenal atrophy is more common than primary adrenal atrophy and is more common in women. Clinical manifestations occur in 30s to 50s in primary and in 60s in secondary adrenal atrophy.

Risk Factor

There are no established risk factors for adrenal atrophy.

Screening

There is insufficient evidence to recommend routine screening for adrenal atrophy. However, the adrenal-hypopituitary axis can be evaluated with sodium, potassium, renin, aldosterone, cortisol, DHEA, ACTH, and CRH levels.

Natural history, complications and prognosis

Adrenal atrophy is mainly due to the prolonged malfunction of the adrenal gland. If left untreated, the patients are mainly at risk of a lethal condition, called adrenal crisis. Common complications of the adrenal atrophy and its malfunction include hypoglycemia, dehydration, weight loss, and disorientation. Prognosis is generally poor, due to the irreversibility of atrophy.

Diagnosis

History and Symptoms

The most common signs and symptoms of adrenal atrophy are fatigue, weight loss, salt craving, abdominal pain and myalgia.

Physical Examination

In the physical examination the patients may have hypotension, hyperpigmentation, depigmentation in autoimmune cases.

Laboratory Findings

The labs include random cortisol, serum ACTH, aldosterone and renin, potassium and sodium, ACTH stimulation test and CRH stimulation test.

Electrocardiogram

There are no specific ECG changes due to adrenal atrophy. However it consequences such as hyperkalemia may change ECG.

X-ray

There are no x-ray findings associated with adrenal atrophy.

Ultrasound

The adrenal glands can be studied in ultrasound imaging and each abdominal ultrasound. Any new incidental mass, larger than 1cm should be evaluated with CT-scan or MRI.

CT scan

A CT of the adrenal glands can be used to check for structural abnormalities of the adrenal glands.

MRI

An MRI of the pituitary can be used to check for structural abnormalities of the pituitary.

Other Imaging Findings

There are no other imaging findings associated with adrenal atrophy.

Other Diagnostic Studies

There are no other diagnostic studies associated with adrenal atrophy.

Treatment

Medical Therapy

Treatment of adrenal atrophy is conservative. In case of adrenal crisis IV fluid and steroid are recommended. For long-term management supplementing with steroid and mineralocorticoid is necessary.

Surgery

Surgery can be done in case of micro or macro adenomas of brain or other glandular tumors that may lead to adrenal atrophy.

Primary Prevention

Primary prevention of the adrenal atrophy consists of avoiding overuse of exogenous corticosteroid drugs.

Secondary Prevention

The secondary prevention of the adrenal atrophy is also known as early diagnosis of any steroid or mineralocorticoid deficiency in the body and its early appropriate treatments.

Cost-Effectiveness of Therapy

There is no cost-effectiveness of therapy for adrenal atrophy.

Future or Investigational Therapies

There are no future or investigational therapies for adrenal atrophy.

References

References

Template:WH Template:WS